connecticut glp 1 #medications #cthealthnews #glp1 #weightmanagement #healthcarepolicy #prescriptiondrugs #connecticutnews Connecticut could make history as

Mounjaro is the latest GLP-1 to enter the increasingly crowded and complex GLP-1 market, joining Ozempic (indicated for diabetes, 2017) and Wegovy (indicated for weight loss, 2021) among others

WHAT'S INSIDE?- GLP-1 Probiotic is formulated with the beneficial bacterial strains that help you produce more GLP-1, based on preclinical studies

Finding the right weight loss medication can be hard

health care, noting that as of June 2023 there were 132 active shortages 58% of which were in shortage for over 2 years

Learn how GLP-1 medications impact libido, hormones, and sexual function in women, plus strategies to manage changes.